Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wissmann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Pathways targeting tumor lymphangiogenesisChristoph Wissmann, Michael Detmar
Cancer Research|January 18, 2008
Regulation of vascular endothelial growth factor D by orphan receptors hepatocyte nuclear factor-4 alpha and chicken ovalbumin upstream promoter transcription factors 1 and 2Georgia Schäfer, Christoph Wissmann, Johannes Hertel, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2014
Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3Johannes Hertel, Christoph Hirche, Christoph Wissmann, et al.
Molecular Carcinogenesis|October 21, 2011
Microarray meta-analysis defines global angiogenesis-related gene expression signatures in human carcinomasMario Anders, Marion Fehlker, Qing Wang, et al.
The Prostate|December 14, 2002
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinomaStefan Jüttner, Christoph Wissmann, Thomas Jöns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladderPeter J Wild, Alexander Herr, Christoph Wissmann, et al.
Clinical Chemistry and Laboratory Medicine|October 2, 2015
Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trialAlexander Kutz, Pierre Hausfater, Michael Oppert, et al.
The Journal of Pathology|October 1, 2003
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancerChristoph Wissmann, Peter Johannes Wild, Simone Kaiser, et al.
The Journal of Pathology|November 9, 2004
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survivalGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Pathways targeting tumor lymphangiogenesisChristoph Wissmann, Michael Detmar
Cancer Research|January 18, 2008
Regulation of vascular endothelial growth factor D by orphan receptors hepatocyte nuclear factor-4 alpha and chicken ovalbumin upstream promoter transcription factors 1 and 2Georgia Schäfer, Christoph Wissmann, Johannes Hertel, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2014
Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3Johannes Hertel, Christoph Hirche, Christoph Wissmann, et al.
Molecular Carcinogenesis|October 21, 2011
Microarray meta-analysis defines global angiogenesis-related gene expression signatures in human carcinomasMario Anders, Marion Fehlker, Qing Wang, et al.
The Prostate|December 14, 2002
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinomaStefan Jüttner, Christoph Wissmann, Thomas Jöns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladderPeter J Wild, Alexander Herr, Christoph Wissmann, et al.
Clinical Chemistry and Laboratory Medicine|October 2, 2015
Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trialAlexander Kutz, Pierre Hausfater, Michael Oppert, et al.
The Journal of Pathology|October 1, 2003
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancerChristoph Wissmann, Peter Johannes Wild, Simone Kaiser, et al.
The Journal of Pathology|November 9, 2004
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survivalGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Pageof 2